Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy

Tumor lysis syndrome (TLS) is a potentially life-threatening complication of cancer therapy characterized by two or more of the following laboratory abnormalities: hyperuricemia, hyperkalemia, hypocalcemia, and hyperphosphatemia, with resultant end-organ damage, eg, renal failure, seizures, or cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinnel, Jennifer, Moore, Bonny L, Skiver, Brent M, Bose, Prithviraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298251/
https://www.ncbi.nlm.nih.gov/pubmed/25610345
http://dx.doi.org/10.2147/CE.S54995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298251/
https://www.ncbi.nlm.nih.gov/pubmed/25610345
http://dx.doi.org/10.2147/CE.S54995

Ejemplares similares